InnovAge Holding Corp. (OTCMKTS:INNV - Get Free Report) shares traded down 4.6% during mid-day trading on Thursday . The stock traded as low as $4.55 and last traded at $4.58. 28,264 shares changed hands during mid-day trading, a decline of 26% from the average session volume of 38,268 shares. The stock had previously closed at $4.80.
InnovAge Stock Down 3.1 %
The business has a fifty day moving average of $5.40 and a 200-day moving average of $5.53. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.57 and a quick ratio of 1.57. The stock has a market cap of $601.42 million, a PE ratio of -37.00 and a beta of 0.31.
InnovAge (OTCMKTS:INNV - Get Free Report) last released its quarterly earnings results on Tuesday, September 10th. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.02) by $0.01. InnovAge had a negative net margin of 6.17% and a negative return on equity of 13.04%. The firm had revenue of $199.40 million for the quarter, compared to analyst estimates of $190.19 million. Equities research analysts anticipate that InnovAge Holding Corp. will post -0.25 earnings per share for the current year.
InnovAge Company Profile
(
Get Free Report)
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
Featured Stories
Before you consider InnovAge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.
While InnovAge currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.